Deina H Walsh insider trades: Bone Biologics (BBLG) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Deina reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 13, 2023 | BBLG | ↑ Buy | 8,000 | $0.64 | $5K | Direct | Sep 14, 2023 (1d) |
| Sep 6, 2023 | BBLG | ↑ Buy | 7,000 | $0.71 | $5K | Direct | Sep 7, 2023 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Deina H Walsh's insider trades
Deina H Walsh is Chief Financial Officer at Bone Biologics (BBLG). Since Sep 6, 2023, Deina has reported 2 open-market purchases worth $10K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (9 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BBLG insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.